HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Qingxin Liu Selected Research
Qingxin Liu Research Topics
Disease
12
Neoplasms (Cancer)
04/2023 - 10/2010
6
Neoplasm Metastasis (Metastasis)
04/2023 - 07/2010
5
Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 07/2010
4
Prostatic Neoplasms (Prostate Cancer)
06/2013 - 05/2010
3
Thrombosis (Thrombus)
01/2016 - 01/2011
2
Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2014
2
Hemorrhage
01/2020 - 01/2011
1
Vascular Remodeling
11/2023
1
Myocardial Infarction
09/2022
1
Hypoxia (Hypoxemia)
01/2022
1
Osteoporosis
01/2022
1
Body Weight (Weight, Body)
11/2021
1
Carcinogenesis
10/2020
1
Hepatic Encephalopathy
01/2020
1
Newcastle Disease
01/2019
1
Obstructive Jaundice (Cholestatic Jaundice)
07/2018
1
Endometrial Neoplasms (Endometrial Cancer)
01/2018
1
Stomach Neoplasms (Stomach Cancer)
01/2018
1
Myxoma (Myxomas)
01/2017
1
Ovarian Neoplasms (Ovarian Cancer)
01/2017
1
Triple Negative Breast Neoplasms
04/2016
1
Weight Loss (Weight Reduction)
01/2016
1
Neuroblastoma
09/2013
1
Vomiting
01/2012
1
Diarrhea
01/2012
1
Neutropenia
01/2012
1
Melena
01/2011
1
Abdominal Pain (Pain, Abdominal)
01/2011
1
Venous Thrombosis (Deep-Vein Thrombosis)
01/2011
Drug/Important Bio-Agent (IBA)
3
Epidermal Growth Factor (EGF)
IBA
01/2023 - 10/2020
3
Iodine-125
IBA
07/2018 - 02/2014
2
Monoclonal Antibodies
IBA
12/2022 - 10/2010
2
Proteins (Proteins, Gene)
FDA Link
09/2022 - 10/2020
2
Tumor Biomarkers (Tumor Markers)
IBA
01/2018 - 01/2017
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2017 - 04/2016
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2012 - 07/2010
2
Irinotecan (Camptosar)
FDA Link
Generic
01/2012 - 07/2010
2
Ligands
IBA
09/2011 - 05/2010
2
Platelet-Derived Growth Factor
IBA
10/2010 - 05/2010
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2023
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2023
1
Transcription Factors (Transcription Factor)
IBA
04/2023
1
APT
IBA
04/2023
1
Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)
IBA
01/2023
1
LGK974
IBA
12/2022
1
Chromatin
IBA
12/2022
1
Cetuximab (Erbitux)
FDA Link
12/2022
1
villin
IBA
12/2022
1
Nerve Growth Factor (NGF)
IBA
09/2022
1
anisodamine
IBA
09/2022
1
Tirofiban (Aggrastat)
FDA Link
09/2022
1
Polyamines
IBA
01/2022
1
Ubiquitin-Specific Proteases
IBA
01/2022
1
Long Noncoding RNA
IBA
01/2022
1
Enzymes
IBA
01/2022
1
JNK Mitogen-Activated Protein Kinases
IBA
01/2022
1
Ornithine
IBA
01/2022
1
Urea (Carbamide)
FDA Link
Generic
01/2022
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
01/2022
1
Selenium
IBA
11/2021
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
01/2020
1
POU Domain Factors
IBA
01/2020
1
Polytetrafluoroethylene (Teflon)
FDA Link
01/2020
1
Aldehyde Dehydrogenase 1 Family
IBA
01/2020
1
COP9 Signalosome Complex
IBA
01/2020
1
Polysaccharides (Glycans)
IBA
01/2019
1
Vaccines
IBA
01/2019
1
Ethanol (Ethyl Alcohol)
IBA
01/2019
1
Metals
IBA
07/2018
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2018
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2018
1
Biomarkers (Surrogate Marker)
IBA
01/2017
1
Cisplatin (Platino)
FDA Link
Generic
01/2017
1
MTOR Inhibitors
IBA
04/2016
1
Dopamine (Intropin)
FDA Link
Generic
09/2013
1
1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)
IBA
09/2013
1
Prostate-Specific Antigen (Semenogelase)
IBA
06/2013
1
Protease Inhibitors (Protease Inhibitor)
IBA
06/2013
1
Chemokine CXCL6
IBA
06/2013
1
Elafin
IBA
06/2013
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
06/2013
1
Synaptophysin
IBA
06/2013
1
Conditioned Culture Media
IBA
06/2013
1
Cytokines
IBA
06/2013
1
Transaminases (Aminotransferases)
IBA
01/2012
1
Floxuridine (FUdR)
FDA Link
Generic
01/2012
1
Bilirubin
IBA
01/2012
1
Apigenin
IBA
12/2011
1
MAP Kinase Kinase Kinase 1
IBA
12/2011
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
09/2011
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
01/2011
Therapy/Procedure
6
Therapeutics
09/2022 - 10/2010
2
Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2020 - 01/2011
2
Brachytherapy
07/2018 - 01/2016
1
Percutaneous Coronary Intervention
09/2022
1
Secondary Prevention
01/2020
1
Transjugular Intrahepatic Portasystemic Shunt
01/2020
1
Stents
07/2018
1
Drug Therapy (Chemotherapy)
01/2012
1
Thrombectomy
01/2011